Clinical Trial Update: Timing of Meal Insulin Boluses for Optimal Postprandial Glycemic Control in Type 1 Diabetes [NA]

View source ↗

Summary

A completed clinical trial investigated the optimal timing of meal insulin boluses to improve postprandial glycemic control in individuals with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | NA | Status: COMPLETED